Monday, October 07, 2019
Yet another mostly male microbiome meeting - #YAMMMM - a microbiome #manel in San Diego
Well, just when I thought the microbiome space was getting better about diversity of speakers. I got called twice today from someone trying to get me to sign up for this meeting and I got an email about it too.
The meeting: "Gen-Next Probiotics and Microbiome - Advanced Therapeutics and Sequencing Congress” to be held on 6th and 7th February 2020 in San Diego, USA."
Speakers from the email:
• Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
• Bharath Prithiviraj, Senior Scientist, City university of New York
• Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals
• Seth Crosby, Director, Research Collaborations, Washington University School of Medicine
• Elliot Friedman, Senior Research Investigator, University of Pennsylvania
• Peter Leighton, CEO, ProSperity Bioscience
• Tal Korem, Assistant Professor, Columbia University in New York City
• Chuck Collins, Professor, East Tennessee State University
• Joseph C Ellis, Sr. Staff Scientist, OAK Ridge National Laboratory
• Aubrey Levitt, CEO/Co-Founder, Postbiotics +
• M. Andrea Azcarate-Peril, Director, Microbiome Core Facility, University of North Carolina
• Arun Bhunia, Professor of Food Microbiology, Purdue University
• A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation
• Michael Leonidas Chikindas, Microbiologist, Rutgers University
I looked up these people and their descriptions on various websites and with this information and other I assigned them to M vs F. I realize this approach is imperfect. I label my inferences below: M in yellow and F in green.
• Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
• Bharath Prithiviraj, Senior Scientist, City university of New York
• Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals
• Seth Crosby, Director, Research Collaborations, Washington University School of Medicine
• Elliot Friedman, Senior Research Investigator, University of Pennsylvania
• Peter Leighton, CEO, ProSperity Bioscience
• Tal Korem, Assistant Professor, Columbia University in New York City
• Chuck Collins, Professor, East Tennessee State University
• Joseph C Ellis, Sr. Staff Scientist, OAK Ridge National Laboratory
• Aubrey Levitt, CEO/Co-Founder, Postbiotics +
• M. Andrea Azcarate-Peril, Director, Microbiome Core Facility, University of North Carolina
• Arun Bhunia, Professor of Food Microbiology, Purdue University
• A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation
• Michael Leonidas Chikindas, Microbiologist, Rutgers University
So that comes to 11M vs 3F.
Or ~ 80% M.
No thanks. I will skip this YAMMMM. And you should too.
Subscribe to:
Post Comments (Atom)
Most recent post
My Ode to Yolo Bypass
Gave my 1st ever talk about Yolo Bypass and my 1st ever talk about Nature Photography. Here it is ...
-
See Isolation and sequence-based characterization of a koala symbiont: Lonepinella koalarum Paper based on PhD thesis work of Katie Dahlha...
-
Just got this press release by email. I am sick of receiving dozens of unsolicited press releases, especially those in topics not related ...
-
I have a new friend in Google Scholar Updates I have written about the Updates system before and if you want more information please see...
No comments:
Post a Comment